Q8CIS0
Gene name |
Card11 (Carma1) |
Protein name |
Caspase recruitment domain-containing protein 11 |
Names |
CARD-containing MAGUK protein 1 , Carma 1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:108723 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
2-115 (CARD domain);152-447 (Coiled-coil domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

2 structures for Q8CIS0
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
4I16 | X-ray | 175 A | A | 18-110 | PDB |
AF-Q8CIS0-F1 | Predicted | AlphaFoldDB |
No variants for Q8CIS0
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q8CIS0 |
No associated diseases with Q8CIS0
5 GO annotations of cellular component
Name | Definition |
---|---|
CBM complex | A protein complex comprising Bcl10, MALT1 and a CARD domain-containing protein (CARD9, CARD10 or CARD11); plays a role in signal transduction during NF-kappaB activation. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
immunological synapse | An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. |
membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
2 GO annotations of molecular function
Name | Definition |
---|---|
CARD domain binding | Binding to a CARD (N-terminal caspase recruitment) domain, a protein-protein interaction domain that belongs to the death domain-fold superfamily. These protein molecule families are similar in structure with each consisting of six or seven anti-parallel alpha-helices that form highly specific homophilic interactions between signaling partners. CARD exists in the N-terminal prodomains of several caspases and in apoptosis-regulatory proteins and mediates the assembly of CARD-containing proteins that participate in activation or suppression of CARD carrying members of the caspase family. |
protein self-association | Binding to a domain within the same polypeptide. |
23 GO annotations of biological process
Name | Definition |
---|---|
B cell differentiation | The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. |
B cell proliferation | The expansion of a B cell population by cell division. Follows B cell activation. |
canonical NF-kappaB signal transduction | The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription. |
CD4-positive, alpha-beta T cell proliferation | The expansion of a CD4-positive, alpha-beta T cell population by cell division. |
homeostasis of number of cells | Any biological process involved in the maintenance of the steady-state number of cells within a population of cells. |
lymphocyte activation | A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor. |
positive regulation of B cell proliferation | Any process that activates or increases the rate or extent of B cell proliferation. |
positive regulation of canonical NF-kappaB signal transduction | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
positive regulation of CD4-positive, alpha-beta T cell proliferation | Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation. |
positive regulation of interleukin-2 production | Any process that activates or increases the frequency, rate, or extent of interleukin-2 production. |
positive regulation of NF-kappaB transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
positive regulation of T cell activation | Any process that activates or increases the frequency, rate or extent of T cell activation. |
positive regulation of T cell receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
protein homooligomerization | The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
regulation of B cell differentiation | Any process that modulates the frequency, rate or extent of B cell differentiation. |
regulation of immune response | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
regulation of T cell differentiation | Any process that modulates the frequency, rate or extent of T cell differentiation. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
T cell activation | The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
T cell costimulation | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation. |
thymic T cell selection | The process of T cell selection that occurs in the thymus. |
TORC1 signaling | A series of intracellular molecular signals mediated by TORC1; TOR (target of rapamycin) in complex with at least Raptor (regulatory-associated protein of TOR), or orthologs of, and other signaling components. |
21 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q12959 | DLG1 | Disks large homolog 1 | Homo sapiens (Human) | SS |
Q92796 | DLG3 | Disks large homolog 3 | Homo sapiens (Human) | SS |
Q15700 | DLG2 | Disks large homolog 2 | Homo sapiens (Human) | SS |
P78352 | DLG4 | Disks large homolog 4 | Homo sapiens (Human) | SS |
Q9BXL7 | CARD11 | Caspase recruitment domain-containing protein 11 | Homo sapiens (Human) | EV |
Q9H257 | CARD9 | Caspase recruitment domain-containing protein 9 | Homo sapiens (Human) | EV |
Q62108 | Dlg4 | Disks large homolog 4 | Mus musculus (Mouse) | SS |
Q811D0 | Dlg1 | Disks large homolog 1 | Mus musculus (Mouse) | SS |
P70175 | Dlg3 | Disks large homolog 3 | Mus musculus (Mouse) | SS |
Q91XM9 | Dlg2 | Disks large homolog 2 | Mus musculus (Mouse) | SS |
Q99KF0 | Card14 | Caspase recruitment domain-containing protein 14 | Mus musculus (Mouse) | PR |
A2AIV8 | Card9 | Caspase recruitment domain-containing protein 9 | Mus musculus (Mouse) | EV |
Q62936 | Dlg3 | Disks large homolog 3 | Rattus norvegicus (Rat) | SS |
Q63622 | Dlg2 | Disks large homolog 2 | Rattus norvegicus (Rat) | EV |
Q62696 | Dlg1 | Disks large homolog 1 | Rattus norvegicus (Rat) | SS |
P31016 | Dlg4 | Disks large homolog 4 | Rattus norvegicus (Rat) | SS |
G5ECY0 | dlg-1 | Disks large homolog 1 | Caenorhabditis elegans | SS |
Q28C55 | dlg1 | Disks large homolog 1 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | SS |
Q6R005 | dlg4 | Disks large homolog 4 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q5PYH5 | dlg1l | Discs large homolog 1-like protein | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
Q5PYH7 | dlg2 | Disks large homolog 2 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MPGGGPAMDD | YMETLKDEEE | ALWDNVECNR | HMLSRYINPA | KLTPYLRQCK | VIDEQDEDEV |
70 | 80 | 90 | 100 | 110 | 120 |
LNAPMLPSKI | NRAGRLLDIL | HTKGQRGYVV | FLESLEFYYP | ELYKLVTGKE | PTRRFSTIVV |
130 | 140 | 150 | 160 | 170 | 180 |
EEGHEGLTHF | LMNEVIKLQQ | QVKAKDLQRC | ELLAKSRQLE | DEKKQLSLIR | VELLTFQERY |
190 | 200 | 210 | 220 | 230 | 240 |
YKMKEERDSY | NDELVKVKDD | NYNLAMRYAQ | LSEEKNMAVM | RSRDLQLEID | QLKHRLNKME |
250 | 260 | 270 | 280 | 290 | 300 |
EECKLERNQS | LKLKNDIENR | PRKEQVLELE | RENEMLKTKI | QELQSIIQAG | KRSLPDSDKA |
310 | 320 | 330 | 340 | 350 | 360 |
ILDILEHDRK | EALEDRQELV | NKIYNLQEEV | RQAEELRDKY | LEEKEDLELK | CSTLGKDCEM |
370 | 380 | 390 | 400 | 410 | 420 |
YKHRMNTVML | QLEEVERERD | QAFHSRDEAQ | TQYSQCLIEK | DKYRKQIREL | EEKNDEMRIE |
430 | 440 | 450 | 460 | 470 | 480 |
MVRREACIVN | LESKLRRLSK | DNGSLDQSLP | RHLPATIISQ | NLGDTSPRTN | GQEADDSSTS |
490 | 500 | 510 | 520 | 530 | 540 |
EESPEDSKYF | LPYHPPRRRM | NLKGIQLQRA | KSPISMKQAS | EFQALMRTVK | GHEEDFTDGS |
550 | 560 | 570 | 580 | 590 | 600 |
PSSSRSLPVT | SSFSKMQPHR | SRSSIMSITA | EPPGNDSIVR | RCKEDAPHRS | TVEEDNDSCG |
610 | 620 | 630 | 640 | 650 | 660 |
FDALDLDDEN | HERYSFGPPS | IHSSSSSHQS | EGLDAYDLEQ | VNLMLRKFSL | ERPFRPSVTS |
670 | 680 | 690 | 700 | 710 | 720 |
GGHVRGTGPL | VQHTTLNGDG | LITQLTLLGG | NARGSFIHSV | KPGSLAERAG | LREGHQLLLL |
730 | 740 | 750 | 760 | 770 | 780 |
EGCIRGERQS | VPLDACTKEE | ARWTIQRCSG | LITLHYKVNH | EGYRKLLKEM | EDGLITSGDS |
790 | 800 | 810 | 820 | 830 | 840 |
FYIRLNLNIS | SQLDACSMSL | KCDDVVHVLD | TMYQDRHEWL | CARVDPFTDQ | DLDTGTIPSY |
850 | 860 | 870 | 880 | 890 | 900 |
SRAQQLLLVK | LQRLVHRGNR | EEADSAHHTL | RSLRNTLQPE | EMLSTSDPRV | SPRLSRASFF |
910 | 920 | 930 | 940 | 950 | 960 |
FGQLLQFVSR | SENKYKRMNS | NERVRIISGS | PLGSLSRSSL | DATKLLTEKH | EELDPENELS |
970 | 980 | 990 | 1000 | 1010 | 1020 |
RNLTLIPYSL | VRAFHCERRR | PVLFTPTMLA | KTLVQKLLNS | GGAMEFTICK | SDIVTRDEFL |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
RKQKTETIIY | SREKNPNTFE | CIVPANIEAV | AAKNKHCLLE | AGIGCVRDLI | KCKVYPIVLL |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
IRVSEKNIKR | FRKLLPRPET | EEEFLRVCRL | KEKELEALPC | LYATVEAEMW | SSVEELLRVL |
1150 | |||||
KDKIVEEQRK | TIWVDEDQL |